v3.26.1
Condensed Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Mar. 05, 2025
Balance, shares at Mar. 05, 2025      
Net loss (46,095) (46,095)
Issuance of Class B ordinary shares to Sponsor [1],[2] $ 604 24,396 25,000
Issuance of Class B ordinary shares to Sponsor, shares [1],[2]   6,037,500      
Balance at Mar. 31, 2025 $ 604 24,396 (46,095) (21,095)
Balance, shares at Mar. 31, 2025 6,037,500      
Balance at Mar. 05, 2025
Balance, shares at Mar. 05, 2025      
Accretion for Class A ordinary shares to redemption amount         (22,012,880)
Balance at Dec. 31, 2025 $ 64 $ 604 (8,409,124) (8,408,456)
Balance, shares at Dec. 31, 2025 638,000 6,037,500      
Accretion for Class A ordinary shares to redemption amount (2,150,115) (2,150,115)
Net loss 1,481,846 1,481,846
Balance at Mar. 31, 2026 $ 64 $ 604 $ (9,077,393) $ (9,076,725)
Balance, shares at Mar. 31, 2026 638,000 6,037,500      
[1] On May 2, 2025, and on May 12, 2025, the Company effected a share capitalization pursuant to which the Company issued an additional 1,725,000 Founder Shares to the Sponsor and the independent director nominees for no additional consideration, resulting in an aggregate of 6,037,500 Founder Shares issued and outstanding. All share and per share data is retroactively presented (see Note 4 and Note 6).
[2] On May, 14, 2025, the underwriters exercised their over-allotment in full as part of the closing of the Initial Public Offering. As such, the 787,500 Founder Shares are no longer subject to forfeiture (See Note 4).